Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI: a Prospective，Muhicenter,Doubleblind, Double-dummy, Randomized, Controlled Trial

NCT03809273 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT03809273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03809273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI: a Prospective，Muhicenter,Doubleblind, Double-dummy, Randomized, Controlled Trial
Lead sponsor
Shenyang Northern Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2019
Completion date
December 31, 2020
Enrollment
681 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous coronary intervention